Work

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

Year: 2021

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccell.2021.12.014

Authors: Cong Zeng, John P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No-Joon Song, Mark P. Rubinstein, Peter G. Shields, Zihai Li, Shan-Lu Liu

Institutions: The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Pelotonia, The Ohio State University Wexner Medical Center

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Ohio State University, Pelotonia, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef, G1858189645, G36614667, G5520316217, Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease, Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy, Integration of inflammation and cancer by molecular chaperone, Molecular chaperones and immune tolerance, G9000065363, G9000266250, Overcoming hypoxic resistance to anti-cancer therapy, Cancer Center Support Grant

OpenAlex ID: W4200054119

FWCI: 5.643

Cites: 12

Cited by: 76

Related to: 10